Neopharm Co Ltd (092730 KS): Synthetic Expert Call Transcript (24 Aug 2026)
The legacy domestic growth engine has hit a structural ceiling. The tightening of private medical indemnity insurance (silbi) reimbursement rules...
94 Views
Primer: Neopharm Co Ltd (092730 KS) - Oct 2025
Proprietary Technology Driving Brand Strength: Neopharm's core competitive advantage lies in its patented Multi-Lamellar Emulsion (MLE)...
436 Views
Launch of the First CJ Olive Young Cosmetics Store in Pasadena, CA - Why Is This A Key Catalyst?
The launch of the first CJ Olive Young cosmetics stores in Pasadena, California, could serve as a positive catalyst for the Korean cosmetics...
114 Views
Innovative Foods = Portfolio Outperformance
We highlight 9 major new innovative products in the Korean F&B sector introduced in the past six months that are having significant impact on...
4.1k Views
Manyo Factory IPO Valuation Analysis
Our base case valuation of Manyo Factory is target price of 29,555 won per share, which represents 111% higher than the high end of the IPO price...
609 Views